α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinic...
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
High-grade gliomas including glioblastoma multiforme (GBM) are among the most malignant and aggressive of tumors, and have a very poor prognosis despite a temozolomide-based intensive treatment. Therefore, a novel therapeutic approach to controlling recurrence is needed. In the present study, we investigated the effect of activated dendritic cell (...
Alternative Titles
Full title
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b5f1cbcb397447fd95884fadc21667f8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b5f1cbcb397447fd95884fadc21667f8
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/1471-2407-12-623
